Exact Sciences Corporation

BMV:EXAS * 株式レポート

時価総額:Mex$252.9b

Exact Sciences 過去の業績

過去 基準チェック /06

Exact Sciences's earnings have been declining at an average annual rate of -2.5%, while the Biotechs industry saw earnings growing at 13.2% annually. Revenues have been growing at an average rate of 22.2% per year.

主要情報

-2.5%

収益成長率

2.1%

EPS成長率

Biotechs 業界の成長12.9%
収益成長率22.2%
株主資本利益率-5.5%
ネット・マージン-6.7%
次回の業績アップデート05 Nov 2024

最近の業績更新

Recent updates

収支内訳

Exact Sciences の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

BMV:EXAS * 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
30 Jun 242,612-1751,645458
31 Mar 242,535-2401,655441
31 Dec 232,500-2041,638426
30 Sep 232,406-2821,625405
30 Jun 232,301-4321,612385
31 Mar 232,200-5171,624387
31 Dec 222,084-6241,640393
30 Sep 222,005-7161,695388
30 Jun 221,938-7351,682372
31 Mar 221,852-7451,609372
31 Dec 211,767-5961,538386
30 Sep 211,760-7931,370744
30 Jun 211,712-8291,249700
31 Mar 211,546-7201,126626
31 Dec 201,491-8241,071554
30 Sep 201,321-327961151
30 Jun 201,131-165875154
31 Mar 201,062-136802151
31 Dec 19876-213738140
30 Sep 19724-216606116
30 Jun 19623-22155199
31 Mar 19526-21949384
31 Dec 18454-17542767
30 Sep 18399-14336960
30 Jun 18353-12432654
31 Mar 18308-11929349
31 Dec 17266-11426342
30 Sep 17214-13024137
30 Jun 17169-14121932
31 Mar 17133-15520531
31 Dec 1699-16719033
30 Sep 1679-17017636
30 Jun 1663-17516738
31 Mar 1650-16915437
31 Dec 1539-15814034
30 Sep 1527-15012830
30 Jun 1514-13911228
31 Mar 156-1209027
31 Dec 142-1006929
30 Sep 141-805130
30 Jun 142-593328
31 Mar 143-522828
31 Dec 134-472427

質の高い収益: EXAS * is currently unprofitable.

利益率の向上: EXAS * is currently unprofitable.


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: EXAS * is unprofitable, and losses have increased over the past 5 years at a rate of 2.5% per year.

成長の加速: Unable to compare EXAS *'s earnings growth over the past year to its 5-year average as it is currently unprofitable

収益対業界: EXAS * is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (4.5%).


株主資本利益率

高いROE: EXAS * has a negative Return on Equity (-5.48%), as it is currently unprofitable.


総資産利益率


使用総資本利益率


過去の好業績企業の発掘